Big Tech Earnings, Semis Sell-Off, and a Record from Taiwan
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Earnings Season in Full Swing
The week's dominant story is a packed earnings calendar. Microsoft and Amazon both report this week, with a combined market cap above $6.5 trillion. Chipotle and Intel follow later in the week. On Tuesday, Coca-Cola and S&P Global are up early. Options markets are pricing in volatility across the board. Intel heads into its print with an RSI of 33, up 136% year-to-date but stalling.
Chips Under Pressure
The semiconductor sector is taking hits ahead of results. Onto Innovation dropped 10% in a week, dragging peers lower. KLA Corp now trades at an RSI of 23, deeply oversold, and has lost 88% year-to-date. Analysts still see 60% upside from current levels. Lam Research is also caught in the crossfire despite being up 79% year-to-date. Short sellers added to positions in AI infrastructure plays too. CoreWeave saw its short interest climb to 24.8% of free float, up 3.6 percentage points in seven days.
Europe: Automakers Face a Weak Quarter
Three major European carmakers report Thursday and Wednesday. ORTEX alt data tracking Dutch car registrations leads Mercedes-Benz revenue by 26 days with a strong fit. That dataset is running 6% below the same quarter last year. Volkswagen faces a similar signal: Austrian registrations, which lead VW revenue by 18 days, are also down 6% year-on-year. Renault gets a more mixed read. Austrian data points to plus 6%, but Dutch registrations run minus 19%.
Taiwan Orders at Record High
Away from earnings, Taiwan's export orders hit $95.7 billion in September 2026, the highest reading since the series began in 1984, according to the Taiwan Ministry of Economic Affairs. That beat the previous record of $84.3 billion. The data supports the bull case for global chip demand even as individual names sell off.
Analyst Moves: Datadog Gets a Lift
Datadog picked up a Bernstein upgrade that reset consensus higher. Merck also saw its target raised to $159.76. On the other side, GE, Honeywell, and Abbott all had targets trimmed after Q3 results, even where numbers came in ahead of expectations.
Stocks in this article
- MSFTMSFT data on ORTEX
- AMZNAMZN data on ORTEX
- CMGCMG data on ORTEX
- INTCINTC data on ORTEX
- KOKO data on ORTEX
- SPGISPGI data on ORTEX
- ONTOONTO data on ORTEX
- KLACKLAC data on ORTEX
- LRCXLRCX data on ORTEX
- CRWVCRWV data on ORTEX
- MBGMBG data on ORTEX
- VOW3VOW3 data on ORTEX
- RNORNO data on ORTEX
- DDOGDDOG data on ORTEX
- MRKMRK data on ORTEX
- GEGE data on ORTEX
- HONHON data on ORTEX
- ABTABT data on ORTEX
How this article was generated
- Generated
- 24 Oct 2026, 20:50
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowORTEX Alpha signalsORTEX Alpha signalsAnalyst consensusAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.